Evidence map›Paper›PMID 31478401›Full record

ReviewExpert review of hematology2019

An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Marena R Niewisch, Sharon A Savage

Registry-linked trialAbstract readReview
In one paragraph

Review in Expert review of hematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04959188 (Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita), which is not on this map. Cited by 99 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04959188 completednot on this mapstarted 2021, after this paper: background citation

Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)

TypeobservationalSponsorNational Cancer Institute (NCI)Ran2021 to 2023Enrolled53ConditionsDyskeratosis Congenita, Telomere Biology Disorders
3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Dyskeratosis Congenita: Clinical Phenotype and Genetic Features in a Sibling Pair.Clinical, cosmetic and investigational dermatology · 2026
    Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marena R NiewischClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Sharon A SavageClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Funding

Clinical Genetic Studies of Familial and Hereditary Cancer SyndromesZIACP010144 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$111.8M
Intramural NIH HHS ZIA CP010144
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dyskeratosis CongenitaGerm-Line MutationTelomereHumansbone marrow failurecancerCoats plusdyskeratosis congenitaHoyeraal-Hreidarsson syndromepulmonary fibrosisRevesz syndromeTelomeretelomere biology disorder

Identifiers

PMID31478401
PMCPMC9400112

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.